{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:24Z","timestamp":1767134784685,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007336.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":22,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007336.pub3","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:34:49Z","timestamp":1346783689000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis"],"prefix":"10.1002","volume":"2017","author":[{"given":"Judith","family":"Thornton","sequence":"first","affiliation":[{"name":"National Institute for Health and Care Excellence; Centre for Clinical Practice; Level 1A, City Tower, Piccadilly Plaza Manchester UK M1 4BD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyapal","family":"Rangaraj","sequence":"additional","affiliation":[{"name":"Queens Medical Centre; Children's Services; Nottingham University Hospital NHS Trust Derby Road Nottingham UK NG7 2UH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD007336.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2006.07.001","article-title":"Cystic fibrosis mortality trends in France","volume":"6","author":"Bellis","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1002\/14651858.CD007336.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/29.4.301","article-title":"Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management","volume":"29","author":"Bemjamin","year":"1990","journal-title":"British Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD007336.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1297-319X(03)00063-0","article-title":"Musculoskeletal manifestations in cystic fibrosis","volume":"70","author":"Botton","year":"2003","journal-title":"Joint Bone Spine"},{"issue":"6420","key":"10.1002\/14651858.CD007336.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.288.6420.822","article-title":"Hypertrophic osteoarthropathy in cystic fibrosis","volume":"288","author":"Braude","year":"1984","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007336.pub3-BIB0005|cit5","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: \u00a0Analysing data and undertaking meta-analyses\u00a0 In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007336.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.47.3.218","article-title":"The arthropathy of cystic fibrosis","volume":"47","author":"Dixey","year":"1988","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007336.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0761-8425(05)85617-7","article-title":"Polyarthrite rhumatoide et mucoviscidose","volume":"22","author":"Doyen","year":"2005","journal-title":"Revue des Maladies Repsiratoires"},{"issue":"1","key":"10.1002\/14651858.CD007336.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD007336.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007336.pub3-BIB0010|cit10","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD007336.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0954-6111(05)80003-4","article-title":"Arthropathy in cystic fibrosis","volume":"88","author":"Johnson","year":"1994","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD007336.pub3-BIB0012|cit12","unstructured":"Jones AP Riley R Williamson PR Whitehead A Meta-analysis of longitudinal data Royal Statistical Society Annual Conference 2005"},{"key":"10.1002\/14651858.CD007336.pub3-BIB0013|cit13","unstructured":"Khan AN Al-Salman MJ Seriki DM Turnbull I MacDonald S Hypertrophic Osteoarthropathy www.emedicine.com\/radio\/topic357.htm"},{"issue":"9","key":"10.1002\/14651858.CD007336.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/rheumatology\/kel215a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years)","volume":"45","author":"Luqmani","year":"2006","journal-title":"Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD007336.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/1529-0131(199908)42:8<1563::AID-ANR1>3.0.CO;2-H","article-title":"Rheumatic disease and cystic fibrosis","volume":"42","author":"Merkel","year":"1999","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD007336.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3476(79)80018-9","article-title":"Episodic arthritis in children with cystic fibrosis","volume":"94","author":"Newman","year":"1979","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD007336.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0049-0172(86)90018-1","article-title":"The musculoskeletal manifestations of cystic fibrosis","volume":"15","author":"Rush","year":"1986","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD007336.pub3-BIB0018|cit18","first-page":"319","article-title":"Serpopositive rheumatoid arthritis in a patient with cystic fibrosis","volume":"134","author":"Sagransky","year":"1980","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD007336.pub3-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006838.pub3","article-title":"Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis","author":"Thornton","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 31","key":"10.1002\/14651858.CD007336.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/014107689709031S04","article-title":"Joint disorders in cystic fibrosis","volume":"90","author":"Turner","year":"1997","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007336.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00006454-199701000-00034","article-title":"Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones","volume":"16","author":"Warren","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD007336.pub3-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007336.pub2","article-title":"Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis","author":"Thornton","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007336.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T21:44:47Z","timestamp":1686174287000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007336.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007336.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}